Lipopolysaccharide-stimulated whole blood cytokine production does not predict the inflammatory response in human endotoxemia

Abstract

A widely applied method to study the activation of the innate immune system is in vitro stimulation of whole blood using lipopolysaccharide (LPS). However, it is unclear if in vitro cytokine production relates to in vivo cytokine levels elicited during experimental endotoxemia or sepsis. To determine the correlation between in vitro cytokine production and the in vivo inflammatory response, blood was obtained from 15 healthy volunteers for in vitro incubation with Escherichia coli LPS, immediately followed by experimental E. coli endotoxemia. Correlations of in vitro and peak in vivo cytokine concentrations were determined using Pearson correlation coefficient. In stimulated whole blood, tumor necrosis factor (TNF)-α, Interleukin (IL)-1β, IL-6, IL-10 and interferon (IFN)-γ were induced to 279 ± 53, 392 ± 64, 5312 ± 624, 83 ± 20 and 343 ± 85 pg/ml, respectively, whereas in vivo cytokine induction led to cytokine levels of 603 ± 123, 11 ± 1, 4999 ± 1228, 167 ± 25 and 194 ± 40 pg/ml, respectively. Correlation coefficients between the in vitro and in vivo cytokine concentrations were for TNF-α, IL-1β, IL-6, IL-10 and IFN-γ -0.10 (P = 0.7), 0.09 (P = 0.8), 0.36 (P = 0.2), 0.19 (P = 0.5) and 0.40 (P = 0.1), respectively. Comparison between in vitro and in vivo stimulation with LPS shows no correlation between the amount of cytokines produced. In vitro cytokine production, therefore, does not predict the in vivo inflammatory response.

Keywords

cytokine human endotoxemia lipopolysaccharide sepsis whole blood stimulation

References

Rivers EP , Kruse JA , Jacobsen G. et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35: 2016-2024.

Gogos CA , Drosou E. , Bassaris HP , Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000; 181: 176-180.

Osuchowski MF , Welch K. , Siddiqui J. , Remick DG Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/ CARS continuum in sepsis and predict mortality . J Immunol 2006; 177: 1967-1974.

Lowry SF Human endotoxemia: a model for mechanistic insight and therapeutic targeting . Shock 2005; 24 (Suppl 1): 94-100.

de Kruif M. , Lemaire LC , Giebelen IA et al. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 2007; 178: 1845-1851.

Suffredini AF , Fromm RE , Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-287.

Heemskerk S. , Pickkers P. , Bouw MP et al. Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 2006; 1: 853-862.

Pickkers P. , Dorresteijn MJ , Bouw MP , van der Hoeven JG , Smits P. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation 2006; 114: 414-421.

Pleiner J. , Heere-Ress E. , Langenberger H. et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002; 22: 95-100.

10.

Cavaillon JM , Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006; 12: 151-170.

11.

Giroir BP , Johnson JH , Brown T. , Allen GL , Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia . J Clin Invest 1992; 90: 693-698.

12.

Meisner M. , Muller V. , Khakpour Z. , Toegel E. , Redl H. Induction of procalcitonin and proinflammatory cytokines in an hepatic baboon endotoxin shock model. Shock 2003; 19: 187-190.

13.

Netea MG , Kullberg BJ , Blok WL , Netea RT , van der Meer JW The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 1997; 89: 577-582.

14.

Draisma A. , Pickkers P. , Bouw MP , van der Hoeven JG Development of endotoxin tolerance in humans in vivo. Crit Care Med 2009; 37: 1261-1267.

15.

Dorresteijn MJ , van Eijk LT , Netea MG , Smits P. , van der Hoeven JG , Pickkers P. Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 2005; 11: 287-293.

16.

Prabhakar U. , Eirikis E. , Davis HM Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 2002; 260: 207-218.

17.

Arcaroli J. , Fessler MB , Abraham E. Genetic polymorphisms and sepsis. Shock 2005; 24: 300-312.

18.

van Eijk LT , Dorresteijn MJ , Smits P. , van der Hoeven JG , Netea MG , Pickkers P. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 2007; 35: 1464-1469.

19.

Cavaillon JM , dib-Conquy M. , Fitting C. , Adrie C. , Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003; 35: 535-544.

20.

Jellema WT , Veerman DP , De Winter RJ et al. In vivo interaction of endotoxin and recombinant bactericidal/permeability-increasing protein (rBPI23): hemodynamic effects in a human endotoxemia model. J Lab Clin Med 2002; 140: 228-235.

21.

van Deventer SJ , Buller HR , ten Cate JW , Aarden LA , Hack CE , Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways . Blood 1990; 76: 2520-2526.

22.

Myrianthefs P. , Karatzas S. , Venetsanou K. et al. Seasonal variation in whole blood cytokine production after LPS stimulation in normal individuals. Cytokine 2003; 24: 286-292.

23.

Van der Linden MW , Huizinga TW , Stoeken DJ , Sturk A. , Westendorp RG Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods 1998; 218: 63-71.

24.

Cirelli RA , Carey LA , Fisher JK et al. Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor-alpha. J Leukoc Biol 1995; 57: 820-826.

25.

Holzer K. , Schubel F. , Konietzny P. , Wilhelm K. , Bechstein WO , Henrich D. Interleukin 8 mRNA gene expression in peripheral and intra-abdominal neutrophils during human secondary peritonitis. Shock 2005; 23: 501-506.

26.

Colbert LH , Davis JM , Essig DA , Ghaffar A. , Mayer EP Tissue expression and plasma concentrations of TNFalpha, IL-1beta, and IL-6 following treadmill exercise in mice. Int J Sports Med 2001; 22: 261-267.

27.

Li YY , Wong LY , Cheung BM , Hwang IS , Tang F. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo. Clin Exp Pharmacol Physiol 2005; 32: 1110-1118.

28.

Zhao K. , Kirman I. , Tschepen I. , Schwab R. , Weksler ME Peritoneal lavage reduces lipopolysaccharide-induced elevation of serum TNF-alpha and IL-6 mortality in mice. Inflammation 1997 ; 21: 379-390.

29.

30.

Krabbe KS , Bruunsgaard H. , Hansen CM et al. Ageing is associated with a prolonged fever response in human endotoxemia . Clin Diagn Lab Immunol 2001; 8: 333-338.

31.

Bruunsgaard H. , Pedersen AN , Schroll M. , Skinhoj P. , Pedersen BK Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 1999; 118: 235-241.

32.

Call DR , Remick DG Low molecular weight heparin is associated with greater cytokine production in a stimulated whole blood model. Shock 1998 ; 10: 192-197.

33.

Heinzelmann M. , Miller M. , Platz A. , Gordon LE , Herzig DO , Polk Jr HC Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes. Ann Surg 1999; 229: 542-550.

34.

Heinzelmann M. , Bosshart H. Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes. J Immunol 2005; 174: 2280-2287.

35.

Schumacher K. , Korr S. , Vazquez-Jimenez JF , von BG , Duchateau J. , Seghaye MC

Does cardiac surgery in newborn infants compromise blood cell reactivity to endotoxin?

Crit Care 2005; 9: R549-R555.

36.

Clinchy B. , Fransson A. , Druvefors B. et al. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma. Cancer 2007; 109: 1742-1749.

37.

Heagy W. , Hansen C. , Nieman K. et al. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify ‘septic’ intensive care unit patients. Shock 2000; 14: 271-276.

38.

Heagy W. , Nieman K. , Hansen C. , Cohen M. , Danielson D. , West MA Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg Infect (Larchmt) 2003; 4: 171-180.